Caroline Diorio

Children's Hospital of Philadelphia — United States

Medicine · Health Sciences

32h-index3.9kcitations189works5.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Lymphoblastic Leukemia research(76), CAR-T cell therapy research(41), Kawasaki Disease and Coronary Complications(17), Immune Cell Function and Interaction(16), COVID-19 Clinical Research Studies(15)

Publications188 total

FOXA1 and RAB25 as Biomarkers of Breast Cancer Cell Response to CYP1A1-Activated Prodrugs: Insights from CEU-938
Pharmaceuticals·2026Open Access
Correction: Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia
Blood Cancer Discovery·2026Open Access
CCR4 expression defines a targetable subset of T-cell acute lymphoblastic leukemia
Blood Advances·2026Open Access
CD19 CAR T-cell Therapy in Infant B-ALL: Durable Remissions, Relapse Patterns, and Molecular Correlates
Transplantation and Cellular Therapy·2026
Next Generation Sequencing Minimal Residual Disease in Pediatric B-ALL after CD19 and/or CD22 CAR T-cell Therapy: Depth and Kinetics of Response Predict Relapse Risk.
Transplantation and Cellular Therapy·2026
High Rates of Clinically Significant Late Infections and Recurrent Sinopulmonary Disease in Long-Term Survivors after CD19 CAR T-cell Therapy for Pediatric B-ALL
Transplantation and Cellular Therapy·2026
CD4+ T cells mediate CAR-T cell-associated immune-related adverse events after BCMA CAR-T cell therapy
Nature Medicine·2026
Paediatric cerebrospinal fluid immune profiling distinguishes paediatric-onset multiple sclerosis from other paediatric-onset acute neurological disorders
EBioMedicine·2026Open Access
Hematopoietic cell transplantation after CD19-directed CAR T-cell therapy for remission consolidation or relapse treatment in pediatric acute lymphoblastic leukemia
Haematologica·2025Open Access
Humanized CD19 chimeric antigen receptor (CAR) T-cell therapy for high-risk and post-CAR relapse of B-cell acute lymphoblastic leukemia
Blood·2025
Platelet factor 4 (PF4) modulates endothelial cell antimicrobial activity to enhance bacterial clearance and improve sepsis outcomes
Blood·2025Open Access
CD19 CAR T cell therapy is an effective strategy for first CNS relapse in pediatric b ALL
Blood·2025Open Access
CD123-directed chimeric antigen receptor T-cell (CART123) therapy for relapsed/refractory pediatric acute myeloid leukemia
Blood·2025
Delayed neurotoxicity, enterocolitis, and BCMA-CART-associated immune-related adverse events (CirAE)  are caused by CD4+ CAR T-cells
Blood·2025
Supplementary Figures S1-S11 from Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia
2025Open Access
Table S8 from Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia
2025Open Access
Table S9 from Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia
2025Open Access
Table S4 from Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia
2025Open Access
Table S6 from Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia
2025Open Access
Table S10 from Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia
2025Open Access
page 1 of 10Next →

Frequent Co-authors

David T. Teachey(22), Edward M. Behrens(16), Hamid Bassiri(15), Lillian Sung(10), Sarah E. Henrickson(9), Stephan A. Grupp(9), Laura A. Vella(8), Kevin O. McNerney(8), Chakkapong Burudpakdee(8), Shannon L. Maude(8), Jessica H. Lee(7), Julie Chase(6), Michele P. Lambert(6), Elizabeth M. Anderson(6), Scott E. Hensley(6), Haley Newman(6), Kathleen Chiotos(5), Audrey R. Odom John(5), Kathleen E. Sullivan(5), Amy E. Baxter(5)